Fig. 4: Importance of lifestyle changes in the era of MASH-specific drugs.
From: The importance of patient engagement in the multimodal treatment of MASLD

Adopting and continuously evaluating lifestyle changes is a priority when initiating MASH-specific drugs to attain metabolic health on a sustainable basis. Therefore, multimodal treatment of MASLD remains an important element even when MASH drugs are available. MASH metabolic dysfunction-associated steatohepatitis, MASLD metabolic dysfunction-associated steatotic liver disease.